For the first time, a vaccine against chlamydia has completed a clinical Phase 1 trial – VacPath

Skip to content Menu Close

Search for:

Search for:

Home
About
PhD Projects
- The PIs
- The Students
Publications
News
- By year
  - News 2018
  - News 2019
- Events
- Press releases
- Media
Contact us

Add custom text here or remove it

Search for:

Home
About
PhD Projects
- The PIs
- The Students
Publications
News
- By year
  - News 2018
  - News 2019
- Events
- Press releases
- Media
Contact us

VacPath
News
News
News 2020
For the first time, a vaccine against chlamydia has completed a clinical Phase 1 trial

VacPathEU 12/02/2020 Media

A chlamydia vaccine is on the horizon

Source Health Europa

Post navigation

Previous Previous post: Kick off meeting

Next Next post: VacPath annual meeting 2020

News

The VacPath Courses, organised by Sclavo Vaccines Association
10/06/2022
The VacPath Courses, organised by Sclavo Vaccines […]
VacPath virtual meeting
05/04/2022
The VacPath Project meeting 2022 was held as online […]
Virtual meeting of the VacPath project
15/02/2021
Due to the COVID-19 crisis, the Vacpath Project […]
VacPath annual meeting 2020
27/04/2020
he VacPath Project meeting 2020 was held as online […]
For the first time, a vaccine against chlamydia has completed a clinical Phase 1 trial
12/02/2020

Legal

Privacy Policy Cookie Policy
Terms and Conditions

Project Lead

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 812915

Coordination team

Browse the website

News
About
Publications

Members area
Privacy Policy

Search for:

Copyright © 2023 VacPath – This project is within the initiatives of Sclavo Vaccines Association, Siena, Italy Business Registration Number*: 92049180521 (*NO VAT subject) – Powered by Wit ICT.

[ Placeholder content for popup link ] WordPress Download Manager - Best Download Management Plugin